)
Visual
test
Theratechnologies
Theratechnologies (TH) investor relations material
Theratechnologies has been acquired
Theratechnologies Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary9 Jul, 2025
Executive summary
Q2 2025 revenue reached $17.7M, with $36.8M for the first half, despite a prior EGRIFTA SVⓇ shortage now resolved.
Adjusted EBITDA remained positive for the fifth consecutive quarter.
Record high patient enrollments for EGRIFTA SVⓇ and stabilized TrogarzoⓇ sales signal a return to growth.
Company entered a definitive agreement to be acquired by an affiliate of Future Pak after quarter end.
Financial highlights
Q2 revenue declined 19.5% year-over-year; first half revenue down 3.9% compared to 2024.
EGRIFTA SVⓇ Q2 net sales fell 31.3% year-over-year due to supply disruption and higher rebates, partially offset by a 5% price increase.
TrogarzoⓇ Q2 net sales rose 13.4% year-over-year, driven by higher unit sales and price.
Adjusted EBITDA was $906K for Q2 and $3.2M for the first half, both down from 2024 due to higher expenses and lower revenue.
Net loss for Q2 was $4.5M versus a net profit of $1.0M in Q2 2024; six-month net loss was $4.3M, up from $3.5M loss in 2024.
Outlook and guidance
Fiscal 2025 revenue and Adjusted EBITDA guidance withdrawn due to pending acquisition.
EGRIFTA WR™ launch in the US expected in Q3 2025, aiming to build on recent momentum.
Explain EGRIFTA SV® sales decrease in Q2 2025.
Assess impact of Future Pak acquisition on guidance.
How will EGRIFTA WR™ impact Adjusted EBITDA?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Theratechnologies
- Q2 delivered revenue growth, first net profit in years, and reaffirmed strong 2024 guidance.TH
Q2 20243 Feb 2026 - Profitability achieved with robust EGRIFTA SV growth, stable Trogarzo, and raised EBITDA guidance.THQ3 202419 Jan 2026
- Record revenue and $20.2M EBITDA achieved, but supply and regulatory risks persist.THQ4 202424 Dec 2025
- Q1 revenue up 17% to $19M; FDA approvals, EGRIFTA SV rebound, and 2025 guidance at $80–83M.THQ1 202528 Nov 2025
- All agenda items, including director elections and incentive plan, passed with strong support.THAGM 202521 Nov 2025
- Achieved financial turnaround and pipeline expansion in HIV, rare diseases, and oncology.THCorporate Presentation3 Jul 2025
Theratechnologies
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage